Stockreport

With 40% ownership, Entrada Therapeutics, Inc. (NASDAQ:TRDA) has piqued the interest of institutional investors [Yahoo! Finance]

Entrada Therapeutics, Inc.  (TRDA) 
PDF A total of 5 investors have a majority stake in the company with 55% ownership Insiders have bought recently A look at the shareholders of Entrada Therapeutics, Inc [Read more]